{
    "title": "Johnson & Johnson's blood cancer therapy gets U.S. FDA approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11354105/Johnson--Johnsons-blood-cancer-therapy-gets-U-S-FDA-approval.html",
    "date": "2022-10-25",
    "keywords": [
        "cancer",
        "myeloma",
        "company",
        "drug",
        "treatment",
        "mandowara",
        "therapy",
        "type",
        "blood",
        "jampjs",
        "tecvayli",
        "month",
        "immune",
        "system",
        "approval",
        "khushi",
        "food",
        "administration",
        "fda",
        "johnson",
        "amp",
        "tuesday",
        "option",
        "teclistamab",
        "spokesperson",
        "price",
        "pricing",
        "course",
        "bispecific",
        "antibody",
        "bodys",
        "class",
        "warning",
        "cytokine",
        "release",
        "condition",
        "toxicity",
        "abecma",
        "relapse",
        "area",
        "need",
        "regulator",
        "bone",
        "marrow",
        "body",
        "societys",
        "year",
        "reporting",
        "raghav",
        "mahobe",
        "amruta",
        "khandekar",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}